MCK McKesson Corporation

Price (delayed)

$151.31

Market cap

$24.54B

P/E Ratio

27.87

Dividend/share

$1.64

EPS

$5.43

Enterprise value

$31.36B

Sector: Healthcare
Industry: Medical Distribution
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Highlights

The company's EPS has surged by 72% YoY and by 9% QoQ
The price to earnings (P/E) is 71% less than the 5-year quarterly average of 97.5
MCK's equity is down by 31% year-on-year but it is up by 7% since the previous quarter
Mckesson's quick ratio has decreased by 5% from the previous quarter and by 5% YoY
Mckesson's gross margin has decreased by 3.7% YoY

Key stats

What are the main financial stats of MCK
Market
Shares outstanding
162.19M
Market cap
$24.54B
Enterprise value
$31.36B
Valuations
Price to earnings (P/E)
27.87
Price to book (P/B)
4.5
Price to sales (P/S)
0.11
EV/EBIT
26
EV/EBITDA
12.23
EV/Sales
0.14
Earnings
Revenue
$231B
EBIT
$1.21B
EBITDA
$2.57B
Free cash flow
$2.85B
Per share
EPS
$5.43
Free cash flow per share
$17.6
Book value per share
$33.65
Revenue per share
$1,425.94
TBVPS
$278.75
Balance sheet
Total assets
$57.67B
Total liabilities
$52.01B
Debt
$9.43B
Equity
$5.45B
Working capital
$82M
Liquidity
Debt to equity
1.73
Current ratio
1
Quick ratio
0.53
Net debt/EBITDA
2.66
Margins
EBITDA margin
1.1%
Gross margin
5.2%
Net margin
0.4%
Operating margin
1.1%
Efficiency
Return on assets
1.5%
Return on equity
15.9%
Return on invested capital
7.9%
Return on capital employed
6.3%
Return on sales
0.5%
Dividend
Dividend yield
1.08%
DPS
$1.64
Payout ratio
30.2%

MCK stock price

How has the Mckesson stock price performed over time

Financial performance

How have Mckesson's revenue and profit performed over time
Revenue
$231B
Gross profit
$11.94B
Operating income
$2.53B
Net income
$921M
Gross margin
5.2%
Net margin
0.4%
Mckesson's operating income has soared by 76% YoY
Mckesson's operating margin has soared by 57% YoY
MCK's net income has soared by 55% YoY and by 2.3% QoQ
The net margin has grown by 33% year-on-year

Valuation

What is Mckesson stock price valuation
P/E
27.87
P/B
4.5
P/S
0.11
EV/EBIT
26
EV/EBITDA
12.23
EV/Sales
0.14
The company's EPS has surged by 72% YoY and by 9% QoQ
The price to earnings (P/E) is 71% less than the 5-year quarterly average of 97.5
MCK's equity is down by 31% year-on-year but it is up by 7% since the previous quarter
The price to book (P/B) is 25% more than the 5-year quarterly average of 3.6 and 4.7% more than the last 4 quarters average of 4.3
MCK's P/S is 45% below its 5-year quarterly average of 0.2 but 10% above its last 4 quarters average of 0.1
The revenue is up by 6% year-on-year

Efficiency

How efficient is Mckesson business performance
The ROE has soared by 130% YoY and by 13% from the previous quarter
The return on assets has surged by 50% year-on-year
The company's return on sales fell by 17% YoY
The return on invested capital rose by 11% since the previous quarter

Dividends

What is MCK's dividend history
DPS
$1.64
Dividend yield
1.08%
Payout ratio
30.2%
Recent dividends

Financial health

How did Mckesson financials performed over time
The total assets is 11% greater than the total liabilities
Mckesson's total liabilities has decreased by 7% from the previous quarter and by 3% YoY
The total assets has declined by 7% year-on-year and by 6% since the previous quarter
The debt is 73% greater than the equity
Mckesson's debt to equity has increased by 38% YoY but it has decreased by 7% QoQ
MCK's equity is down by 31% year-on-year but it is up by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.